EGFR/c-Met-IN-2
EGFR/ C-Met-in-2 (Compound H-22) is a dual inhibitor of EGFR/c-Met. EGFR/c-Met-IN-2 inhibits cell proliferation by arresting G2/M phase. EGFR/c-Met-IN-2 has antitumor activity[1].
Product Specifications
CAS Number
[2761180-01-0]
UNSPSC
12352005
Target
C-Met/HGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/egfr-c-met-in-2.html
Solubility
10 mM in DMSO
Smiles
O=C(C=C)NC(C(OC)=C1)=CC2=C1N=CN=C2OC3=CC=C(NC(NCCC4=CC=C(F)C=C4)=O)C=C3F
Molecular Formula
C27H23F2N5O4
Molecular Weight
519.50
References & Citations
[1]Zhang H, et al. Novel quinazoline-based dual EGFR/c-Met inhibitors overcoming drug resistance for the treatment of NSCLC: Design, synthesis and anti-tumor activity. Bioorg Chem. 2024 Jan;142:106938.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15360143 1 Vial
Lentiviral human GMEB2 sgRNA gene knockout kit - Lentiviral human GMEB2 sgRNA gene knockout kit (plasmid)
Ask
View Details 
MBS6475331-01 0.2 mL
EIF4E2 (Eukaryotic Translation Initiation Factor 4E Type 2, eIF4E Type 2, eIF-4E Type 2, mRNA Cap-binding Protein Type 3, Eukaryotic Translation Initiation Factor 4E-like 3, Eukaryotic Translation Initiation Factor 4E Homologous Protein, mRNA Cap-binding
Ask
View Details MBS6475331-02 5x 0.2 mL
EIF4E2 (Eukaryotic Translation Initiation Factor 4E Type 2, eIF4E Type 2, eIF-4E Type 2, mRNA Cap-binding Protein Type 3, Eukaryotic Translation Initiation Factor 4E-like 3, Eukaryotic Translation Initiation Factor 4E Homologous Protein, mRNA Cap-binding
Ask
View Details